Trademark: 97469786
Word
KYTOSIA
Status
Pending
Status Code
688
Status Date
Tuesday, September 12, 2023
Serial Number
97469786
Mark Type
4000
Filing Date
Wednesday, June 22, 2022
Published for Opposition
Tuesday, July 18, 2023

Trademark Owner History
Cellarity, Inc. - Owner At Publication

Classifications
5 Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
44 Diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases
42 Bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks

Trademark Events
Sep 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 18, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Published For Opposition
Jun 28, 2023
Notification Of Notice Of Publication E-Mailed
Jun 14, 2023
Approved For Pub - Principal Register
Jun 14, 2023
Examiner's Amendment Entered
Jun 14, 2023
Notification Of Examiners Amendment E-Mailed
Jun 14, 2023
Examiners Amendment E-Mailed
Jun 14, 2023
Examiners Amendment -Written
Jun 6, 2023
Teas/Email Correspondence Entered
Jun 5, 2023
Correspondence Received In Law Office
Jun 5, 2023
Teas Response To Office Action Received
Feb 23, 2023
Application Extension Granted/Receipt Provided
Feb 23, 2023
Application Extension To Response Period - Received
Dec 5, 2022
Notification Of Non-Final Action E-Mailed
Dec 5, 2022
Non-Final Action E-Mailed
Dec 5, 2022
Non-Final Action Written
Oct 20, 2022
Assigned To Examiner
Jul 9, 2022
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24